“We are delighted to have achieved the first milestone in drug discovery research targeting previously challenging targets identified by Ono.”, said Dai Takehara, President & CEO of PRISM BioLab.
“We are delighted to have achieved the first milestone in drug discovery research targeting previously challenging targets identified by Ono.”, said Dai Takehara, President & CEO of PRISM BioLab.